Updates are available Correction dated 2025-04-10
Click to view Correction: https://doi.org/10.1186/s40164-025-00650-7
-
Authors
Kang, HyunJun
Valerio, Melissa
Feng, Jia
Gu, Long
Hoang, Dinh Hoa
Blackmon, Amanda
Sharkas, Shawn
Pathak, Khyatiben
Jossart, Jennifer
Li, Zhuo
Zhang, Hongyu
Zhang, Bin
Pirrotte, Patrick
Perry, J. Jefferson P.
Hickey, Robert J.
Malkas, Linda
Marcucci, Guido
Nguyen, Le Xuan Truong
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572, P30CA33572)
IDDV COH
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 26 November 2024
First Online: 28 December 2024
Change Date: 30 March 2025
Change Type: Update
Change Details: The original online version of this article was revised: Error in the funding and competing interests sections have been corrected
Change Date: 10 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40164-025-00650-7
Declarations
:
: Healthy donor-derived normal hematopoietic stem cells (HSCs) and acute myeloid leukemia (AML) specimens were sourced from the City of Hope National Medical Center (COHNMC) in accordance with approved banking protocols (#06229, #03162, #07047, or #18067) sanctioned by the City of Hope Institutional Review Board. These protocols adhere to the guidelines set forth by the Department of Health and Human Services and are compliant with the principles outlined in the Declaration of Helsinki. Prior to specimen acquisition, written informed consent was obtained from donors (#06229) or patients (#03162, #07047, or #18067).
: LG, JPP, RJH and LM are share holders of RLL Inc. The remaining authors declare that there is no conflict of interest regarding the publication of this article.
